Product Highlight - Firazyr

30 Nov 2021
Product Highlight - Firazyr
Active ingredient: Icatibant acetate.

Indication: Symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adolescents & children aged ≥2 years, w/ C1-esterase-inhibitor deficiency.

Dosage & Administration: 30 mg as single subcutaneous injection.

TAKEDA (THAILAND) LTD
57 Park Ventures Ecoplex Bldg., 15 Fl, Wireless Rd
Lumpini, Patumwan, Bangkok 10330
Tel: (+66) 2697 9300 • Fax: (+66) 2697 9398-9

Related MIMS Drugs